SCHEMBL25979706

SCHEMBL25979706

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cc(-c5ccc(N(c6ccccc6)c6cccc7c6oc6ccccc67)cc5)ccc34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.38
KMT2A Q03164 3/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 2/20 0.36
MMP12 P39900 1/20 0.36
MMP13 P45452 1/20 0.36
ALOX5 P09917 1/20 0.35
HPGD P15428 2/20 0.34
HCRTR1 O43613 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
AHR P35869 1/20 0.33
USP2 O75604 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PRKDC P78527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980335 0.99 MAPT (0.38) MAPTKMT2APOLBTSHRLMNA
SCHEMBL26779114 0.97 MAPT (0.36) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980258 0.97 MAPT (0.34) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980334 0.97 MAPT (0.34) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980061 0.97 MAPT (0.35) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980318 0.97 MAPT (0.35) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980276 0.97 MAPT (0.35) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25979998 0.97 MAPT (0.35) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980257 0.97 MAPT (0.35) MAPTKMT2APOLBTSHRLMNA
SCHEMBL25980336 0.96 MAPT (0.36) MAPTKMT2APOLBTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1428/4885KMT2A 758/4885POLB 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.